Sponsor
David Joyce
Representative · R-OH
Representative · R-OH
Official title: Making appropriations for financial services and general government for the fiscal year ending September 30, 2027, and for other purposes.
Introduced April 24, 2026 by David Joyce
The bill increases congressional oversight, reporting, and certain taxpayer protections (notably at the IRS) while imposing broad restrictions on agency spending, regulatory activity, public‑health measures, and local autonomy—trading greater transparency and partisan policy limits for reduced administrative flexibility, narrower benefits, and potential public‑health, environmental, and fiscal risks.
Most federal spending and transfers will face greater congressional and public transparency and oversight (more reporting, transfer approvals, and OMB cost statements), giving taxpayers and Congress clearer visibility into how agencies use FY2027 funds.
Taxpayers will get improved IRS customer service and stronger protections (better phone support, prioritized help for victims of tax‑related crimes, and enhanced safeguards for return confidentiality and taxpayer rights).
Federal protections for free expression are strengthened by prohibiting use of funds to classify U.S. persons' communications as mis/dis/malinformation or to pressure private platforms to censor lawful speech.
Extensive prohibitions on use of funds combined with tight reprogramming caps and new approval/penalty regimes will reduce agencies' ability to reallocate funds quickly and respond to urgent needs, likely slowing services and operational responses.
The bill bars or limits many regulatory and procurement activities (e.g., DEI programs and training, ESG advisory work, certain rulemakings and SEC climate disclosures, and broad EV procurement bans), which could delay consumer and environmental protections and slow federal modernization efforts.
Health and safety protections are curtailed in multiple ways (prohibiting FEHB coverage for gender‑affirming care, banning COVID‑19 mask/vaccine mandates, and limiting federal support for some harm‑reduction services), reducing access to care and constraining agencies' public‑health responses.
Based on analysis of 10 sections of legislative text.
Conditions FY2027 spending with new transfer limits, reporting and reprogramming rules, IRS protections/training, CPSC rule freezes, pay freezes, contractor eligibility limits, and other fiscal controls.
Sets conditions and limits on how FY2027 federal appropriations may be used across many agencies, with detailed restrictions on IRS operations, OMB transfer authority and cost statements for Executive actions, judiciary funding flexibility, Federal Reserve regulatory threshold changes, and specific limits on Consumer Product Safety Commission rulemaking. The bill also imposes workplace drug‑policy requirements for recipients of appropriated funds, freezes certain senior pay rates for 2027, caps vehicle purchase prices for federal fleets, restricts contracting with firms with tax/conviction problems, and includes multiple reprogramming and transparency requirements for agencies and the District of Columbia. The measure is primarily an appropriations and oversight package that conditions spending, constrains regulatory and rulemaking actions in FY2027 (notably several CPSC rules), and requires various reports, studies, and prior approvals before transfers, reprogrammings, or certain actions can occur. Many provisions take effect upon enactment and apply to fiscal year 2027 funding and to agency practices during that year.